Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Ottawa

$110,000.00

Development and evaluation of decision support for patients to accept or decline ICD replacement at the time of battery depletion: A multi-methods study (4D-ICD)

EF 2015-16

Résumé
The implantable-cardioverter defibrillator (ICD) is a small medical device used to treat dangerously fast and potentially life-threatening heart rates. For patients at risk, the ICD can detect an abnormal rhythm and provide life-saving therapy by delivering a shock. ICD therapy has risks and benefits that should be weighed from each patient's perspective. An ICD battery needs to be surgically replaced every 4 to 7 years to ensure ongoing function. At present, the majority of these batteries are automatically changed without eliciting patients' preferences. There is a need for a better way to engage with patients. Patients want to be involved in their healthcare decisions, yet more than half of patients with an ICD do not know that ICD replacement is optional. To ensure that patients are receiving treatment that they value and want, members of the interprofessional team should ensure that treatment decisions align with patients' expectations, values and preferences. This rests on the principle of shared decision-making in which members of the healthcare team and patients deliberate together to arrive at a decision which best reflects the preferences and values of the patient. To facilitate the achievement of this goal, a patient decision aid (PDA) can be used. As a result, we plan to develop and evaluate a PDA for ICD replacement. First, the PDA will be developed with relevant stakeholders according to international standards. Second, with a pilot randomized controlled trial, we will collect preliminary data to test the feasibility of conducting a larger trial, and to evaluate the PDA for its acceptability and ease of use. Patients facing ICD replacement will be randomized to receive the decision aid or to usual care. We will assess if this decision aid can improve patients' knowledge on ICD therapy and the replacement surgery, increase patients' perceived involvement in the decision, and determine whether their actual choice reflects their personal values.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
338829
Name
Lewis Krystina B
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Allied Health Professionals - Fellowships
Projecttitle
Development and evaluation of decision support for patients to accept or decline ICD replacement at the time of battery depletion: A multi-methods study (4D-ICD)
Programtype2
Fellowship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$110,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Feasibility Testing; Implantable Cardioverter-Defibrillators; Integrated Knowledge Translation; Mixed Methods Research; Patient Decision Aid; Pilot Randomized Controlled Trial; Qualitative Medthods; Shared Decision-Making
Abstract
The implantable-cardioverter defibrillator (ICD) is a small medical device used to treat dangerously fast and potentially life-threatening heart rates. For patients at risk, the ICD can detect an abnormal rhythm and provide life-saving therapy by delivering a shock. ICD therapy has risks and benefits that should be weighed from each patient's perspective. An ICD battery needs to be surgically replaced every 4 to 7 years to ensure ongoing function. At present, the majority of these batteries are automatically changed without eliciting patients' preferences. There is a need for a better way to engage with patients. Patients want to be involved in their healthcare decisions, yet more than half of patients with an ICD do not know that ICD replacement is optional. To ensure that patients are receiving treatment that they value and want, members of the interprofessional team should ensure that treatment decisions align with patients' expectations, values and preferences. This rests on the principle of shared decision-making in which members of the healthcare team and patients deliberate together to arrive at a decision which best reflects the preferences and values of the patient. To facilitate the achievement of this goal, a patient decision aid (PDA) can be used. As a result, we plan to develop and evaluate a PDA for ICD replacement. First, the PDA will be developed with relevant stakeholders according to international standards. Second, with a pilot randomized controlled trial, we will collect preliminary data to test the feasibility of conducting a larger trial, and to evaluate the PDA for its acceptability and ease of use. Patients facing ICD replacement will be randomized to receive the decision aid or to usual care. We will assess if this decision aid can improve patients' knowledge on ICD therapy and the replacement surgery, increase patients' perceived involvement in the decision, and determine whether their actual choice reflects their personal values.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Lewis, Krystina B
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $110,000~ $0~